Insights

04
May
2017

Treatment Option for Hep C in Pediatric Patients - FDA Approval

Can FDA approval of Harvoni provide treatment options for hepatitis C in pediatric patients? Read more to find out the safety and efficacy of Harvoni.
Continue Reading ?
24
Mar
2017

Procalcitonin Assay - Controling Unnecessary Antibiotic Use

Increased antibiotic resistance is becoming an alarming concern. Find out how the Procalcitonin (PCT) Assay can help with antibiotic abuse and why it's FDA approved.
Continue Reading ?
20
Mar
2017

What the Updates to GMP Facility Inspections Mean for US & EU

The US & the EU have amended the Pharmaceutical Annex to the 1998 Mutual Recognition Agreement. Read more to find out the developmental phases.
Continue Reading ?
09
Mar
2017

SLCN Could Open Door for Advanced New Diabetes Treatment

Can synthetic lineage-control network be the next step in diabetic regenerative medicine? Can we solve the problem of beta cell regenerative science?
Continue Reading ?
15
Feb
2017

Amendments to Regulations Governing Medical Devices in the EU

Amendments to regulations governing medical devices in the European Union. What are the proposed changes and what are the implications to manufacturers?
Continue Reading ?
10
Feb
2017

The Chaos of the Sick Heart

Are anti-fibrillation drugs safe to treat ventricular fibrillation? Let's explore the efficacy of anti-fibrillation drugs and the chaotic phemonon of VF.
Continue Reading ?
26
Jan
2017

Chlamydophila Pneumoniae Infection association w/ Heart Disease

In this blog post from CfPIE we explore the controversial association of chlamydophila pneumonia infection with heart disease.
Continue Reading ?
18
Jan
2017

Orphan Drug Dev. & Commercialization - US & EU Perspective

Challenges and opportunities for orphan drug development and commercialization from the US and EU perspective. Find out more in this blog post from CfPIE.
Continue Reading ?
12
Jan
2017

Regulatory Environment for Cell and Gene Therapies

US, EU and Japanese regulatory environment for cell and gene therapies is changing. What hinges on it's success? Read more to stay up to date with CfPIE.
Continue Reading ?
31
Aug
2016

New FDA Guidance on Data Integrity, Classifying Co-Crystals

Find out more about the increased attention the FDA is paying to data integrity issues and new FDA guideline on Co-Crystals in this blog post from CfPIE.
Continue Reading ?
09
Aug
2016

Protecting IP: What Should Medical Marijuana Suppliers Do?

How can medical marijuana suppliers protect their intellectual property? Learn what classes offered by CfPIE can help protect what belongs to you.
Continue Reading ?
25
Apr
2016

FDA Approval & Patent Protection of Medical Marijuana

What would it take to get FDA approval and patent protection for medical marijuana. What obstacles do they face? We explore it all in this blog from CfPIE.
Continue Reading ?
11
Mar
2016

Record New FDA Approvals in 2015, But is That a Guarantee?

The FDA set a record in 2015, approving 45 drugs and more "orphan drugs." What does it mean for the future of FDA drug approval? Read more to find out.
Continue Reading ?
11
Mar
2016

New EU Clinical Trial Regulations Coming. Are You Ready?

Get ready for new EU clinical trail regulations. Read more to see how you can develop an understanding of the new PRIME regulations & achieve compliance.
Continue Reading ?